Literature DB >> 20664895

Interlaboratory variation in heparin monitoring: Lessons from the Quality Management Program of Ontario coagulation surveys.

Adam Cuker1, Anne Raby, Karen A Moffat, Greg Flynn, Mark A Crowther.   

Abstract

Unfractionated heparin (UFH) monitoring is subject to substantial interlaboratory variation. We analysed results of annual coagulation surveys administered by the Quality Management Program - Laboratory Services (Toronto, ON, Canada) from 2003 to 2007 to evaluate variation in UFH monitoring across Ontario. Participating laboratories performed an activated partial thromboplastin time (APTT) utilising their local methodology on lyophilised human plasma spiked with UFH. In the 2006 and 2007 surveys, laboratories licensed to perform anti-Xa assays also reported anti-Xa activity results. The APTT differed significantly between heparin-sensitive and heparin-insensitive methods (p<0.0005). Within-method variation was observed and increased with increasing heparin concentration. Among laboratories performing an APTT and anti-Xa, the coefficient of variation was greater in the anti-Xa than in the APTT for both the 2006 (64.0% vs. 10.5%) and 2007 (15.0% vs. 11.6%) surveys. Substantial interlaboratory variation in UFH monitoring, both between and within APTT methods, was observed and was not reduced by use of an anti-Xa assay.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20664895     DOI: 10.1160/TH10-02-0099

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Concordance between Activated Partial Thromboplastin Time and Antifactor Xa Assay for Monitoring Unfractionated Heparin in Hospitalized Hyperbilirubinemic Patients.

Authors:  Leana Mahmoud; Andrew R Zullo; Donald McKaig; Christine M Berard-Collins
Journal:  R I Med J (2013)       Date:  2016-03-01

Review 4.  Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays.

Authors:  Jonathan Douxfils; Anne Tamigniau; Bernard Chatelain; Catherine Goffinet; Jean-Michel Dogné; François Mullier
Journal:  Thromb J       Date:  2014-11-04

Review 5.  Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism.

Authors:  Maureen A Smythe; Jennifer Priziola; Paul P Dobesh; Diane Wirth; Adam Cuker; Ann K Wittkowsky
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

6.  Establishing the heparin therapeutic range using aPTT and anti-Xa measurements for monitoring unfractionated heparin therapy.

Authors:  Jung-Hyun Byun; In-Seok Jang; Jong Woo Kim; Eun-Ha Koh
Journal:  Blood Res       Date:  2016-09-23

7.  Management of Extremity Venous Thrombosis in Neonates and Infants: An Experience From a Resource Challenged Setting.

Authors:  Ahmed Mousa; Ossama M Zakaria; Ibrahim Hanbal; Mohammed A Nasr; Tamer A Sultan; Mohamed Abd El-Hamid; Amr M El-Gibaly; Haytham Al-Arfaj; Ahmed S Daha; Mohammed A Buhalim; Mohamed Y Zakaria; Dina E El Metwally; Bosat E Bosat; Alaa Sharabi; Mohamed Nienaa; Mahsoub M Amin; Khaled A Rashed
Journal:  Clin Appl Thromb Hemost       Date:  2018-12-06       Impact factor: 2.389

8.  Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study.

Authors:  Michael Nagler; Lucas M Bachmann; Lorenzo Alberio; Anne Angelillo-Scherrer; Lars M Asmis; Wolfgang Korte; Adriana Mendez; Guido Reber; Hans Stricker; Dimitrios A Tsakiris; Walter A Wuillemin
Journal:  Thromb J       Date:  2013-03-07

Review 9.  Updates in Anticoagulation Therapy Monitoring.

Authors:  Hannah L McRae; Leah Militello; Majed A Refaai
Journal:  Biomedicines       Date:  2021-03-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.